Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Gynecology | Internal Medicine | Nursing | Oncology | Pathology | Journal

Back to Journal Articles

Similar Specific Survival for Unilateral, Bilateral Breast CA

Last Updated: November 22, 2011.

 

Synchronous bilateral breast cancer survival similar to unilateral cancer high-risk matches

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
The 10-year breast cancer-specific survival of patients with synchronous bilateral breast cancer and high-risk matches with unilateral breast cancer is not significantly different, according to a study published online Nov. 21 in the Journal of Clinical Oncology.

TUESDAY, Nov. 22 (HealthDay News) -- The 10-year breast cancer-specific survival (BCSS) of patients with synchronous bilateral breast cancer (SBBC) and high-risk matches with unilateral breast cancer is not significantly different, according to a study published online Nov. 21 in the Journal of Clinical Oncology.

Alan M. Nichol, M.D., from the British Columbia Cancer Agency-Vancouver Centre in Canada, and colleagues examined whether survival outcomes for patients with SBBC can be estimated from the characteristics of their individual cancers, in patients with invasive breast cancer, without metastases or inflammatory disease. Between 1989 and 2000, 207 patients with SBBC and 15,497 with unilateral breast cancer were examined. The higher-risk cancer of each case with SBBC was identified and matched with 621 high-risk cases from the unilateral cohort, using 10-year BCSS estimates.

The investigators found that the unilateral cohort had significantly higher overall 10-year BCSS (81 percent) than the SBBC cohort (71 percent), at a median follow-up of 10.2 years. The mean age and stage at presentation was significantly higher for patients with SBBC. The high-risk matches had a 10-year BCSS of 74 percent.

"The SBBC cases had worse BCSS than the unilateral cohort because the higher-risk cancers of the SBBC cases had worse prognostic factors. In the matching analysis, BCSS was equivalent for the SBBC cases and their high-risk matches. Thus, for a patient with SBBC, an appropriate systemic therapy selection can be made by considering the prognosis of their higher-risk cancer," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.


Previous: American Heart Association, Nov. 12-16, 2011 Next: Oliguria in Bariatric Surgery Not Tied to Intra-Op Fluids

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.